SBI-0206965
CAS No. 1884220-36-3
SBI-0206965 ( SBI 0206965;SBI0206965 )
产品货号. M12941 CAS No. 1884220-36-3
SBI-0206965 (SBI 0206965) is a potent and specific small molecule ULK1 kinase inhibitor with IC50 of 108 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥308 | 有现货 |
|
5MG | ¥494 | 有现货 |
|
10MG | ¥818 | 有现货 |
|
25MG | ¥1434 | 有现货 |
|
50MG | ¥2333 | 有现货 |
|
100MG | ¥3629 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SBI-0206965
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SBI-0206965 (SBI 0206965) is a potent and specific small molecule ULK1 kinase inhibitor with IC50 of 108 nM.
-
产品描述SBI-0206965 (SBI 0206965) is a potent and specific small molecule ULK1 kinase inhibitor with IC50 of 108 nM; displays 7-fold less potency for ULK2 (IC50=711 nM); inhibits Beclin1 Ser15 and Vps34 Ser249 phosphorylation to comparable extents in HEK-293T cells; suppresses autophagy induced by mTOR inhibition and prevents ULK1-dependent cell survival; greatly synergized with mTOR inhibitors to kill tumor cells.
-
同义词SBI 0206965;SBI0206965
-
通路Autophagy
-
靶点ULK
-
受体ULK1
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1884220-36-3
-
分子量489.32
-
分子式C21H21BrN4O5
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(NC)C1=CC=CC=C1OC2=NC(NC3=CC(OC)=C(OC)C(OC)=C3)=NC=C2Br
-
化学全称2-((5-bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Egan DF, et al. Mol Cell. 2015 Jul 16;59(2):285-97.
产品手册
关联产品
-
BL-918
BL-918 is a small molecule activator of ULK1 with EC50 of 24 nM (243% kinase activity at 100 nM).
-
ULK-100
ULK-100 (ULK100) is a potent and selective ULK1 inhibitor with in vitro IC50 of 1.6 nM, inhibits ULK2 with IC50 of 2.6 nM.
-
MRT-68921
A potent, relatively specific inhibitor of both ULK1 and ULK2 with IC50 of 2.9 and 1.1 nM, respectively.